Original filing text · Part I

Item 3 — Quantitative and Qualitative Disclosures About Market Risk

Teradyne, Inc. · 10-Q · Q2 FY2026 · Period ended Jun 28, 2026

This is the extracted source text from the SEC filing. Formatting may differ from the original document.

For quantitative and qualitative disclosures about market risk affecting Teradyne, see Part 2 Item 7A, “Quantitative and Qualitative Disclosures about Market Risk,” in our Annual Report on Form 10-K filed with the SEC on February 19, 2026. There were no material changes in our exposure to market risk from those set forth in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025.